Project/Area Number |
22H03308
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 58010:Medical management and medical sociology-related
|
Research Institution | Hitotsubashi University |
Principal Investigator |
Rahman Mizanur 一橋大学, 社会科学高等研究院, 客員准教授 (10726433)
|
Co-Investigator(Kenkyū-buntansha) |
中村 良太 一橋大学, 社会科学高等研究院, 教授 (00717209)
佐藤 主光 一橋大学, 社会科学高等研究院, 教授 (50313458)
ALAM MD・ASHRAFUL 東京大学, 医学部附属病院, 特任研究員 (80866632)
|
Project Period (FY) |
2022-04-01 – 2025-03-31
|
Project Status |
Granted (Fiscal Year 2023)
|
Budget Amount *help |
¥17,030,000 (Direct Cost: ¥13,100,000、Indirect Cost: ¥3,930,000)
Fiscal Year 2023: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
Fiscal Year 2022: ¥8,970,000 (Direct Cost: ¥6,900,000、Indirect Cost: ¥2,070,000)
|
Keywords | Pharmacy / Health promotion / Treatment adherence / Blood pressure / Cluster RCT / hypertension |
Outline of Research at the Start |
This cluster-randomized controlled trial will evaluate the effectiveness of a pharmacy-based health promotion program in lowering blood pressure levels over 12 months among hypertensive subjects in Bangladesh, India and Pakistan. A total of 8,082 adults (2694 each country) with hypertension will be recruited from 60 pharmacies. Equal number of pharmacies will be randomly assigned to either intervention or control group. The intervention will be involved training and counseling of pharmacists, phone call/mobile SMS and care coordination of health sector.
|